These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24439168)

  • 1. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
    Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
    Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
    Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.
    Li G; Bekris LM; Leong L; Steinbart EJ; Shofer JB; Crane PK; Larson EB; Peskind ER; Bird TD; Yu CE
    Alzheimers Dement; 2013 Sep; 9(5):554-61. PubMed ID: 23183136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
    PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
    Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
    J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
    Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.
    Roses AD
    Arch Neurol; 2010 May; 67(5):536-41. PubMed ID: 20457951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease.
    Zeitlow K; Charlambous L; Ng I; Gagrani S; Mihovilovic M; Luo S; Rock DL; Saunders A; Roses AD; Gottschalk WK
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2973-2986. PubMed ID: 28768149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
    Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
    J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.
    Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA
    Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Chiba-Falek O; Gottschalk WK; Lutz MW
    Alzheimers Dement; 2018 May; 14(5):692-698. PubMed ID: 29524426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
    Gottschalk WK; Mahon S; Hodgson D; Barrera J; Hill D; Wei A; Kumar M; Dai K; Anderson L; Mihovilovic M; Lutz MW; Chiba-Falek O
    J Alzheimers Dis; 2023; 94(4):1563-1576. PubMed ID: 37458041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
    Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
    Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population.
    Ortega-Rojas J; Arboleda-Bustos CE; Guerrero E; Neira J; Arboleda H
    Alzheimer Dis Assoc Disord; 2022 Jan-Mar 01; 36(1):29-35. PubMed ID: 35149606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE.
    Bekris LM; Lutz F; Yu CE
    J Hum Genet; 2012 Jan; 57(1):18-25. PubMed ID: 22089642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.
    Bakeberg MC; Hoes ME; Gorecki AM; Theunissen F; Pfaff AL; Kenna JE; Plunkett K; Kõks S; Akkari PA; Mastaglia FL; Anderton RS
    Sci Rep; 2021 Mar; 11(1):6363. PubMed ID: 33737565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.
    Gang Q; Bettencourt C; Machado PM; Fox Z; Brady S; Healy E; Parton M; Holton JL; Hilton-Jones D; Shieh PB; Zanoteli E; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Hanna MG; Houlden H;
    Neurobiol Aging; 2015 Apr; 36(4):1766.e1-1766.e3. PubMed ID: 25670332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.